| Literature DB >> 35997957 |
Diana Khanna1, Jyoti Khadka2,3, Christine Mpundu-Kaambwa2, Kiri Lay2, Remo Russo4,5, Julie Ratcliffe2.
Abstract
OBJECTIVE: The aim of this study was to examine the level of agreement between self- and proxy-reporting of health-related quality of life (HRQoL) in children (under 18 years of age) using generic preference-based measures.Entities:
Mesh:
Year: 2022 PMID: 35997957 PMCID: PMC9550745 DOI: 10.1007/s40273-022-01177-z
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.558
Fig. 1Literature search flow diagram using the PRISMA checklist. PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses. 1Thirty studies were included in the final review. The two papers by Glaser et al., i.e. ‘Standardized quantitative assessment of brain tumor survivors treated within clinical trials in childhood’ [36] and ‘Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the UK’ [37], were published in two different journals but used the same sample to report different results. To prevent double counting, these two papers were considered as one
An overview of the included studies
| Description | No. of studies |
|---|---|
| Total studies included | 30 |
| Child-specific preference-based measures used | |
| HUI2 | 10 |
| HUI3 | 17 |
| EQ-5D-Youth, EQ-5D and EQ VAS | 11 |
| CHU9D | 2 |
| QWB | 1 |
| Health conditioned studied | |
| Cancer or history of cancer | 8 |
| Other health conditions (including general health) | 22 |
| Child proxy pairs (with some studies using more than one proxy type) | |
| Child/parent | 29 |
| Child/health professionals (nurses, physicians, physiotherapists) or teachers | 5 |
| Self-mode of administration for child in the age range | |
| 6–7 years | 3 |
| 8 years and above | 11 |
| Interviewer mode of administration for child in the age range | |
| 6–7 years | 6 |
| 8 years and above | 10 |
| Level of agreement statistics reported | |
| For overall utilities | 25 |
| For attribute-level utilities | 17 |
HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, VAS visual analogue scale, CHU9D Child Health Utility 9 Dimensions, QWB Quality of Well-Being scale
Details of the cancer studies that reported dyad self and proxy HRQoL using preference-based quality-of-life instruments
| Author | Health state experienced | Mean/median age (range) of the child in the dyad (where available) or study | Child sample (male %) included in the dyad (where available) or study | Proxy type ( | Measure | Administration mode child | Quality score |
|---|---|---|---|---|---|---|---|
Barr et al. [ Canada 1999 | Cancer survivors: CNS tumours | 13.5 (9.5–17.9) | 15 (46.3) | Nurses (15), physicians (12) | HUI2/3 | Self-administered | 0.7 |
Glaser et al. [ UK 1999 | Cancer survivors: CNS tumours | 10.5 (6.0–16.0) | 28 | Physiotherapist (30), parents (30), physicians (27) | HUI2/3 | Self and Interviewer administered | 0.85 |
Sung et al. [ Canada 2004 | Cancer patients: rheumatic diseases, haemophilia, conditions requiring bone marrow transplant | 13.7 (12.0–18.0) | 22 (55) | Parents | HUI2 | Self-administered | 0.9 |
Fu et al. [ El Salvador, Honduras, Nicaragua, Panama 2006 | Cancer survivors: leukaemia, lymphoma, renal tumours, germ cell tumours, retinoblastoma, malignant bone tumours, CNS tumours, sympathetic nervous system tumours, soft tissue sarcomas, carcinomas, others | 12.8 (5–25.8) | 211 (52.6) | Parents (180), physicians (201) | HUI2/3 | Interviewer administered | 0.8 |
Banks et al. [ Canada 2008 | Cancer including leukaemia, lymphoma, and brain tumour | 9.5 (10.0–18.0) | 11 (65) | Parents (22) | HUI2/3 | Self-administered | 0.85 |
Fluchel et al. [ Uruguay 2008 | Cancer survivors: ALL, brain tumours, Wilms tumour, retinoblastoma, Hodgkin disease, non-Hodgkin lymphoma, acute myeloid leukaemia, rhabdomyosarcoma, neuroblastoma, Ewing sarcoma, ovarian sarcoma, osteogenic sarcoma | 13.6 (7.0–28.0) | 95 (49.5) | Parents (95) | HUI3 | Interviewer administered | 0.95 |
| General health (control) | 12.2 (8.0–17.0) | 96 (33.3) | Parents (91) | HUI3 | Interviewer administered | ||
Penn et al. [ UK 2011 | Cancer patients: brain tumour | 12.4 (8.0–17.6) | 29 (48.3) | Parents (29) | HUI3 | Interviewer administered | 0.85 |
| General health (control) | 10.7 (8.0–18.9) | 32 (50) | Parents (32) | HUI3 | Interviewer administered | ||
Zhou et al. [ China 2021 | Haematological malignancies | 10.5 (8.0–17.0) | 96 (64.6) | Caregiver (96) | EQ-5D-3L-Y/VAS, EQ-5D-5L-Y | Interviewer administered | 0.95 |
HRQoL health-related quality of life, HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, VAS visual analogue scale, CNS central nervous system, ALL acute lymphoblastic leukaemia
Details of the studies with health conditions other than cancer that reported dyad self and proxy HRQoL using preference-based quality-of-life instruments
| Author | Health state experienced | Mean/median age (range) of the child in the dyad (where available) or study | Child sample (male %) included in the dyad (where available) or study | Proxy type ( | Measure (proxy measure) | Administration mode child | Quality score |
|---|---|---|---|---|---|---|---|
Czyzewski et al. [ USA 1994 | Cystic fibrosis | (12–17.9) | 55 | Parents (199) | QWB | Self-administered | 0.8 |
Verrips et al. [ Netherlands 2001 | Very low birth weight (VLBW): Telephone Face-to-face Repeat mail | 14.2 (14.0) 14.3 (14.0) 14.3 (14.0) 14.2 (14.0) | 486 (49) 100 (54) 103 (51) 203 (52) | Parents (481) Parents (100) Parents (103) Parents (203) | HUI3 HUI3 HUI3 HUI3 | Self-administered Self-administered Self-administered Self-administered | 0.85 |
Brunner et al. [ Canada 2003 | Musculoskeletal disorders | 9 (8.0–18.0) | 55 | Parents (68) | HUI3 | Interviewer administered | 0.8 |
Jelsma and Ramma [ South Africa 2010 | Children with functional impairment General health (control) | (7.0–12.0) (7.0–12.0) | 61 (74) 567 (45) | Mother (57) Mother (530) | EQ-5D-Y/VAS (EQ-5D-Y Proxy 2) EQ-5D-Y/VAS | Self-administered Self-administered | 0.85 |
Belfort et al. [ Germany 2016 | Overweight or obese General health (control) | 10.3 (8.0–17.0) 11.5 (8.0–18.0) | 76 (52.6) | Parents (63) | HUI3 | Interviewer administered | 0.95 |
Lee et al. [ USA 2011 | Type 1 diabetes mellitus. Complications: hypertension, hypercholesterolaemia, cardiovascular disease, renal disease, neurological disease, retinopathy | 13.7 (8.0–18.0) | 231 (48.5) | Parents (223) | HUI3 | Interviewer administered | 0.95 |
Morrow et al. [ Australia 2012 | Chronic illness: any cancer, cystic fibrosis, type 1 diabetes, cerebral palsy (GMFCS V), any chronic neurological condition, liver transplant, inflammatory bowel disease, chronic kidney disease, autism | 12.2 (12.0–18.0) | 69 (54.2) | Parents (129) Physicians (34) | HUI2/3 | Self-administered | 0.85 |
Rhodes et al. [ USA 2012 | Obesity; type 2 diabetes mellitus; prediabetes; insulin resistance | 15.5 (12.0–18.0) | 108 | Parents (108) | HUI3 | Interviewer administered | 0.85 |
Ungar et al. [ Canada 2012 | Asthma | 10.9 (8.0–17.0) | 91 (55) | Parents (91) | HUI2/3 | Interviewer administered | 1 |
Kulpeng et al. [ Thailand 2013 | Common pneumococcal infections and sequelae: meningitis, bacteraemia, pneumonia, AOM, hearing loss, chronic lung disease, epilepsy, MMR, SMR, and MR combined with epilepsy | 10 (7.0–14.0) | 74 | Caregiver (74) | HUI2/3, EQ-5D | Interviewer administered | 0.85 |
Wolke et al. [ Germany 2013 | VLBW/VP | 13 (13.0) | 260 (52) | Parents (260) | HUI3 | Self-administered | 0.85 |
| General health (control) | 13 (13.0) | 282 (49) | Parents (282) | HUI3 | Self-administered | ||
Gusi et al. [ Spain 2014 | General health | (6.0–17.0) | 442 | Mother (442) Father (266) | EQ-5D-Y | Self and interviewer administered | 0.9 |
Sims-Williams [ Uganda 2017 | Open spina bifida; associated complications | (10.0–14.0) | 66 (56) | Caregiver (66) | HUI3 | Interviewer administered | 0.95 |
Bharij et al. [ USA 2017 | Paediatric liver transplant recipients | 13.6 (12.0–21.7) | 108 (44.4) | Parents (108) | HUI2/3, CHU9D | Interviewer administered | 0.9 |
Bray et al. [ UK 2017 | Long-term mobility impairment: cerebral palsy, hemiplegia, muscular dystrophy | (6.0–18.0) | 13 (61.5) | Parents (13) | HUI2/3, EQ-5D-Y/VAS | Self-administered | 0.9 |
Perez Sousa et al. [ Spain 2017 | Cerebral palsy | 10.9 (6.0–17.0) | 62 (65.4) | Mother (62) | EQ-5D-Y/VAS | Interviewer administered | 0.95 |
Perez Sousa et al. [ Spain 2018 | Obesity: exercise Obesity: control | 9.6 (6.0–14.0) 8.7 (6.0–13.0) | 106 (55) 45 (47) | Parents (106) Parents (45) | EQ-5D-Y/VAS EQ-5D-Y/VAS | Interviewer administered Interviewer administered | 0.95 |
van Summeren et al. [ The Netherlands 2018 | Functional constipation | 10 (8.0–18.0) | 56 (43) | Parents (56) | EQ VAS | Self-administered | 0.95 |
Rogers et al. [ Netherlands 2019 | Dental caries | 11 (11.0) | 486 (48) | Parents (486) | CHU9D (NL) | Self-administered | 1 |
Shiroiwa et al. [ Japan 2019 | General health | 11 (8.0–15.0) | 654 (50) | Parents (654) | EQ-5D-Y/VAS | Self-administered | 0.9 |
Sinlapamongkolkul et al. [ Thailand 2020 | Thalassaemia | 9.1 (8.0–18.0) | 85 (54) | Parents (85) | EQ VAS | Self and interviewer administered | 0.95 |
Lin et al. [ Hong Kong 2020 | Adolescent/Juvenile idiopathic sclerosis (AIS/JIS) | 14 (10.0–12.0) | 125 (9.4) | Caregiver (125) | EQ-5D-Y/VAS | Self-administered | 0.95 |
HRQoL health-related quality of life, HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, EQ-5D-Y EQ-5D Youth version, VAS visual analogue scale, CHU9D Child Health Utility 9 Dimensions, CHU9D (NL) CHU9D Dutch version, QWB Quality of Well-Being scale, GMFCS Gross Motor Function Classification System, AOM acute otitis media, MMR mild mental retardation, SMR severe mental retardation, MR mental retardation, VLBW very low birth weight, VP very preterm, AIS adolescent idiopathic scoliosis, JIS juvenile idiopathic scoliosis
Details of the included studies of level of agreement by overall utilities between self- and proxy-reported HRQoL using preference-based quality-of-life instruments
| Authors (intervention) | Measure | Proxy type | Sample size dyad | Correlation test | Correlation coefficient ( | 95% CI |
|---|---|---|---|---|---|---|
| Barr et al. [ | HUI2 | Nurses Physicians | 15 12 | ICC | 0.85 0.95 | |
| Glaser et al. [ | HUI2 | Physiotherapist Parents Physicians | 25 24 19 | ICC | 0.4 0.57 0.15 | |
| Glaser et al. [ | HUI2 | Physiotherapist Parents Physicians | 25 24 19 | Pearson | 0.54 (< 0.01) 0.59 (< 0.01) 0.37 (0.12) | |
| Sung et al. [ | HUI2 | Parents | 19 | ICC Spearman | 0.11 (0.3) 0.14 | − 0.35, 0.53 − 0.34, 0.55 |
| HUI3 | Parents | 19 | ICC Spearman | − 0.01 0.11 | − 0.45, 0.44 0.35, 0.55 | |
| Fu et al. [ | HUI2 | Parents Physicians | 120 156 | ICC | 0.389 0.379 | 0.227, 0.531 0.237, 0.506 |
| HUI3 | Parents Physicians | 156 166 | ICC | 0.433 0.341 | 0.297, 0.552 0.200, 0.469 | |
| Banks et al. [ | HUI2 | Parents | 11 | ICC | 0.74 | 0.29, 0.92 |
| HUI3 | Parents | 11 | ICC | 0.42 | − 0.21, 0.80 | |
| Fluchel et al. [ | HUI3 | Parents Physicians | 92 91 | ICC | 0.3087 0.066 | 0.1125, 0.4818 − 0.1402, 0.2669 |
| Fluchel et al. [ | HUI3 | Physicians/teachers | 89 | ICC | − 0.3103 | − 0.4857, − 0.1106 |
| Penn et al. [ | HUI3 | Parents | 21 | Spearman | 0.76 (< 0.001) | |
| Penn et al. [ | HUI3 | Parents | 22 | Spearman | 0.31 | |
| Zhou et al. [ | EQ VAS | Caregiver | 96 | ICC | 0.22 | |
| Zhou et al. [ | EQ VAS | Caregiver | 96 | Yes | 0.556 | |
| Czyzewski et al. [ | QWB | Parents | 55 | Pearson | 0.39 | |
| Brunner et al. [ | HUI3 | Parents | 45 | ICC Pearson | 0.43 0.57 | |
| Belfort et al. [ | HUI3 | Parents | 63 | Spearman | 0.47 (0.0002) | |
| Lee et al. [ | HUI3 | Parents | 223 | Spearman | 0.34 | 0.22, 0.45 |
| Rhodes et al. [ | HUI3 | Parents | 96 | Spearman | 0.24 (< 0.05) | |
| Ungar et al. [ | HUI2 | Parents | 72 | ICC | 0.021 | − 0.22, 0.262 |
| HUI3 | Parents | 75 | ICC | 0.169 | − 0.070, 0.389 | |
| Ungar et al. [ | HUI2 | Parent with child | 72 | ICC | 0.545 (< 0.0001) | 0.360, 0.689 |
| HUI3 | Parent with child | 75 | ICC | 0.735 (< 0.0001) | 0.611, 0.824 | |
| Kulpeng et al. [ | HUI2 | Caregiver | 74 | Pearson | 0.58 (< 0.05) | |
| HUI3 | Caregiver | 74 | Pearson | 0.67 (< 0.05) | ||
| EQ-5D | Caregiver | 74 | Pearson | 0.77 (< 0.05) | ||
| EQ VAS | Caregiver | 74 | Pearson | 0.5 (< 0.05) | ||
| Sims-Williams et al. [ | HUI3 | Caregiver | 62 | Pearson | 0.848 | |
| Bharij et al. [ | HUI2 | Parents | 61 | ICC | 0.9 (< 0.001) | |
| HUI3 | Parents | 60 | ICC | 0.75 (< 0.001) | ||
| CHU9D | Parents | 96 | ICC | 0.69 (< 0.001) | ||
| Bray et al. [ | HUI2 | Parents | 13 | Spearman | 0.728 (0.005) | |
| HUI3 | Parents | 13 | Spearman | 0.842 (< 0.001) | ||
| EQ-5D-Y | Parents | 11 | Spearman | 0.665 (0.026) | ||
| EQ VAS | Parents | 13 | Spearman | 0.545 (0.054) | ||
| Perez Sousa et al. [ | EQ VAS | Mother Father | 62 62 | ICC | 0.389 (0.029) 0.581 (0.962) | |
| Perez Sousa et al. [ | EQ VAS | Parents | 151 | ICC | 0.5 (< 0.0001) | |
| Perez Sousa et al. [ | EQ VAS | Parents | 151 | ICC | 0.7 (< 0.0001) | |
| van Summeren et al. [ | EQ VAS | Parents | 56 | ICC | 0.78 | 0.65, 0.87 |
| Rogers et al. [ | CHU9D | Parents | 184 | Pearson | 0.156 (0.02) | |
| Rogers et al. [ | CHU9D | Parents | 302 | Pearson | 0.183 (0.01) | |
| Rogers et al. [ | CHU9D | Parents | 386 | Pearson | 0.183 (< 0.001) | |
| Shiroiwa et al. [ | EQ VAS | Parents | 654 | ICC | 0.06 | |
| Sinlapamongkolkul et al. [ | EQ VAS | Caregiver | 85 | Spearman | 0.334 (0.001) | |
| Lin et al. [ | EQ VAS | Caregiver | 125 | Yes | 0.29 |
HRQoL health-related quality of life, CI confidence interval, HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, EQ-5D-Y EQ-5D Youth version, VAS visual analogue scale, CHU9D Child Health Utility 9 Dimensions, QWB Quality of Well-Being scale, ICC intraclass correlation coefficient
Details of the included studies’ level of agreement by domains (attributes) between self- and proxy-reported HRQoL using preference-based quality-of-life instruments
| Authors (intervention) | Measure | Proxy type | Attribute | Statistic reported | Agreement statistic ( | 95% CI |
|---|---|---|---|---|---|---|
| Barr et al. [ | HUI2 | Nurses | Sensation | Cohen’s kappa | 0.05 | |
| Emotion | 0.13 | |||||
| Cognition | 0.54 | |||||
| Pain | 0.71 | |||||
| HUI2 | Physicians | Sensation | Cohen’s kappa | 0.42 | ||
| Emotion | 0.13 | |||||
| Cognition | 0.37 | |||||
| Pain | 0.73 | |||||
| Fu et al. [ | HUI2 | Parents | Sensation | ICC | 0.773 | 0.706, 0.826 |
| Mobility | 0.67 | 0.584, 0.742 | ||||
| Emotion | 0.104 | − 0.058, 0.262 | ||||
| Cognition | 0.121 | − 0.026, 0.263 | ||||
| Self-care | 0.422 | 0.298, 0.532 | ||||
| Pain | 0.14 | − 0.002, 0.277 | ||||
| HUI2 | Physicians | Sensation | ICC | 0.829 | 0.778, 0.870 | |
| Mobility | 0.569 | 0.465, 0.657 | ||||
| Emotion | 0 | − 0.143, 0.143 | ||||
| Cognition | 0.102 | − 0.045, 0.245 | ||||
| Self-care | 0.754 | 0.686, 0.810 | ||||
| Pain | 0.08 | − 0.063, 0.219 | ||||
| Morrow et al. [ | HUI2 | Parents | Sensation | Cohen’s kappa | 0.51 | 0.23, 0.78 |
| Mobility | 0.59 | 0.31, 0.86 | ||||
| Emotion | 0.32 | 0.10, 0.53 | ||||
| Cognition | 0.29 | 0.35, 0.54 | ||||
| Pain | 0.44 | 0.23, 0.64 | ||||
| HUI2 | Physicians | Sensation | Cohen’s kappa | 0.27 | − 0.26, 0.56 | |
| Mobility | 0.62 | 0.37, 0.88 | ||||
| Emotion | 0.18 | − 0.03, 0.88 | ||||
| Cognition | 0.07 | − 0.16, 0.30 | ||||
| Pain | 0.11 | − 0.11, 0.34 | ||||
| HUI3 | Parents | Ambulation | Cohen’s kappa | 0.52 | 0.29, 0.77 | |
| Dexterity | 0.12 | − 0.11, 0.34 | ||||
| Emotion | 0.27 | 0.04, 0.51 | ||||
| Cognition | 0.32 | 0.09, 0.55 | ||||
| Pain | 0.43 | 0.25, 0.62 | ||||
| HUI3 | Physicians | Ambulation | Cohen’s kappa | 0.56 | 0.31, 0.82 | |
| Dexterity | 0.11 | − 0.12, 0.33 | ||||
| Emotion | 0.16 | − 0.05, 0.37 | ||||
| Cognition | 0.05 | − 0.11, 0.20 | ||||
| Pain | 0.36 | 0.17, 0.55 | ||||
| Glaser et al. [ | HUI2 | Physiotherapist | Sensation | Cohen’s kappa | 0.32 | |
| Mobility | NS | |||||
| Emotion | 0.37 | |||||
| Cognition | 0.7 | |||||
| Self-care | 0.43 | |||||
| Pain | NS | |||||
| HUI2 | Parents | Sensation | Cohen’s kappa | 0.54 | ||
| Mobility | 0.72 | |||||
| Emotion | 0.37 | |||||
| Cognition | NS | |||||
| Self-care | 0.47 | |||||
| Pain | 0.62 | |||||
| HUI2 | Physicians | Sensation | Cohen’s kappa | 0.38 | ||
| Mobility | 0.77 | |||||
| Emotion | NS | |||||
| Cognition | NS | |||||
| Self-care | 0.78 | |||||
| Pain | NS | |||||
| Glaser et al. [ | HUI3 | Physiotherapist | Vision | Cohen’s kappa | 0.62 | |
| Hearing | 0.12 | |||||
| Speech | 0.64 | |||||
| Ambulation | 0.19 | |||||
| Dexterity | 0.77 | |||||
| Emotion | 0.4 | |||||
| Pain | 0.33 | |||||
| HUI3 | Parents | Vision | Cohen’s kappa | 0.62 | ||
| Hearing | 0.49 | |||||
| Speech | 0.47 | |||||
| Ambulation | 0.73 | |||||
| Dexterity | 0.82 | |||||
| Emotion | 0.28 | |||||
| Pain | 0.56 | |||||
| HUI3 | Physicians | Vision | Cohen’s kappa | 0.6 | ||
| Hearing | 0.67 | |||||
| Speech | 0.14 | |||||
| Ambulation | 0.77 | |||||
| Dexterity | 0.48 | |||||
| Emotion | 0.14 | |||||
| Pain | 0.14 | |||||
| Ungar et al. [ | HUI2 | Parents | Mobility | ICC | 0.108 | − 0.101, 0.308 |
| Emotion | 0.065 | − 0.155, 0.278 | ||||
| HUI2 | Parent with child | Mobility | ICC | 0.713 | 0.593, 0.802 | |
| Emotion | 0.468 | 0.281, 0.621 | ||||
| Verrips et al. [ | HUI3 | Parents | Vision | Cohen’s kappa | 0.87 | |
| Hearing | 0.33 | |||||
| Speech | 0.23 | |||||
| Ambulation | 0.66 | |||||
| Dexterity | 0.63 | |||||
| Emotion | 0.29 | |||||
| Cognition | 0.36 | |||||
| Pain | 0.43 | |||||
| Verrips et al. [ | HUI3 | Parents | Vision | Cohen’s kappa | 0.69 | |
| Speech | 0.21 | |||||
| Ambulation | 0.73 | |||||
| Dexterity | 0.61 | |||||
| Emotion | 0.2 | |||||
| Cognition | 0.17 | |||||
| Pain | 0.22 | |||||
| Verrips et al. [ | HUI3 | Parents | Vision | Cohen’s kappa | 0.75 | |
| Hearing | 0 | |||||
| Speech | 0.19 | |||||
| Ambulation | 0.39 | |||||
| Dexterity | 0.8 | |||||
| Emotion | 0.07 | |||||
| Cognition | 0.09 | |||||
| Pain | 0.08 | |||||
| Wolke et al. [ | HUI3 | Parents | Vision | Cohen’s kappa | 0.87 | 0.88, 0.86 |
| Hearing | 0.59 | 0.59, 0.59 | ||||
| Speech | 0.22 | 0.22, 0.22 | ||||
| Ambulation | 0.78 | 0.78, 0.78 | ||||
| Dexterity | 0.67 | 0.68, 0.66 | ||||
| Emotion | 0.41 | 0.42, 0.4 | ||||
| Cognition | 0.32 | 0.32, 0.32 | ||||
| Pain | 0.48 | 0.49, 0.47 | ||||
| Wolke et al. [ | HUI3 | Parents | Vision | Cohen’s kappa | 0.82 | 0.81, 0.83 |
| Hearing | 1 | 0.99, 1.01 | ||||
| Speech | 0.23 | 0.23, 0.23 | ||||
| Dexterity | 0.67 | 0.66, 0.68 | ||||
| Emotion | 0.37 | 0.36, 0.38 | ||||
| Cognition | 0.2 | 0.2, 0.2 | ||||
| Pain | 0.46 | 0.45, 0.47 | ||||
| Gusi et al. [ | Pain or discomfort | 0.68 (< 0.05) | ||||
| Worried, sad, or unhappy | 0.221 (< 0.05) | |||||
| Jelsma and Ramma [ | EQ-5D-Y | Mother | Mobility Self-care Doing usual activities Pain or discomfort Worried, sad, or unhappy | Cohen’s kappa | 0.15 | |
| 0.08 | ||||||
| 0.01 | ||||||
| 0.2 | ||||||
| 0.21 | ||||||
| Jelsma and Ramma [ | EQ-5D-Y | Mother | Mobility Self-care Doing usual activities Pain or discomfort Worried, sad, or unhappy | Cohen’s kappa | 0.6 | |
| 0.33 | ||||||
| 0.34 | ||||||
| 0.41 | ||||||
| 0.22 | ||||||
| Perez Sousa et al. [ | EQ-5D-Y | Mother | Mobility Self-care Doing usual activities Pain or discomfort Worried, sad, or unhappy | Cohen’s kappa | 0.713 (< 0.001) | |
| 0.057 (0.536) | ||||||
| 0.436 (< 0.001) | ||||||
| 0.128 (0.183) | ||||||
| 0.165 (0.14) | ||||||
| EQ-5D-Y | Father | Mobility Self-care Doing usual activities Pain or discomfort Worried, sad, or unhappy | Cohen’s kappa | 0.042 (0.653) | ||
| 0.044 (0.622) | ||||||
| 0.019 (0.841) | ||||||
| 0.067 (0.469) | ||||||
| 0.016 (0.854) | ||||||
| Perez Sousa et al. [ | EQ-5D-Y | Parents | Mobility Self-care Doing usual activities Pain or discomfort Worried, sad, or unhappy Mobility | Cohen’s kappa | 0.51 (< 0.001) | |
| 0.36 (< 0.001) | ||||||
| 0.22 (< 0.001) | ||||||
| 0.27 (< 0.001) | ||||||
| 0.42 (< 0.001) | ||||||
| Perez Sousa et al. [ | EQ-5D-Y | Parents | Cohen’s kappa | 0.15 (0.03) | ||
| Self-care | 0.13 (0.04) | |||||
| Doing usual activities | 0.09 (0.19) | |||||
| Pain or discomfort | 0.26 (< 0.001) | |||||
| Worried, sad, or unhappy | 0.37 (< 0.001) | |||||
| Shiroiwa et al. [ | EQ-5D-Y | Parents | Mobility Self-care Doing usual activities Pain or discomfort Worried, sad, or unhappy | Cohen’s kappa | 0.5 0.91 0.78 0.15 0.12 |
HRQoL health-related quality of life, CI confidence interval, HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, EQ-5D-Y EQ-5D Youth version, ICC intraclass correlation coefficient, NS non-significant
Fig. 2Summary of the interrater reliability across studies. The forrest plot depicts the study-specific and overall estimates of ICCs, their respective 95% CIs and the study weight (%) for 24 studies obtained using a random effects model. ICCs intraclass correlation coefficients, CIs confidence intervals
Domain (attribute)-level overall kappa estimates with their 95% CIs for HUI2 and 3
| Attribute | Agreement ( | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| HUI2 | |||
| Self-care | 0.576 | 0.347 | 0.806 |
| Cognition | 0.296 | 0.088 | 0.505 |
| Emotion | 0.250 | 0.158 | 0.342 |
| Mobility | 0.615 | 0.463 | 0.767 |
| Pain | 0.385 | 0.148 | 0.622 |
| Sensation | 0.409 | 0.306 | 0.512 |
| HUI3 | |||
| Ambulation | 0.641 | 0.535 | 0.747 |
| Cognition | 0.229 | 0.145 | 0.313 |
| Dexterity | 0.646 | 0.541 | 0.751 |
| Emotion | 0.272 | 0.190 | 0.353 |
| Hearing | 0.497 | 0.232 | 0.762 |
| Pain | 0.361 | 0.265 | 0.457 |
| Speech | 0.300 | 0.174 | 0.427 |
| Vision | 0.782 | 0.713 | 0.850 |
CIs confidence intervals, HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, estimated kappa value
| The application of child-specific preference-based measures enables the calculation of utilities for cost utility analysis of health technologies targeted for paediatric populations. |
| Proxy reports (e.g., parent/guardian or a health professional), used in lieu of child self-reports in circumstances when self-reports are not feasible, can often diverge from the child’s assessment of their own HRQoL. |
| This review examined the agreement between the child self- and proxy-reported overall and domain-level HRQoL using generic preference-based measures. |
| In general, the inter-rater agreement was poor for overall utilities across the measure/s applied and/or the context of the application. In addition, the agreement between children and proxy respondents within the domains of the respective measures was lower for psychosocial-related attributes compared with physical attributes. |